Infinity Pharmaceuticals, Inc. INFI has an Earnings ESP of +5.81% and a Zacks Rank #1. Click to get this free report ARIAD PHARMA (ARIA): Free Stock Analysis Report IMMUNOGEN INC (IMGN): Free Stock Analysis Report INFINITY PHARMA (INFI): Free Stock Analysis Report AMERISOURCEBRGN (ABC): Free Stock Analysis Report To read this article on Zacks.com click here. Factors Influencing this Quarter AmerisourceBergen's pharmaceutical distribution segment continues to face headwinds in the form of contract renewals and lower generic inflation.